Urinary TWEAK as a biomarker of lupus nephritis: a multicenter cohort study. - Wikidata - awgldk - TriplyDB

Urinary TWEAK as a biomarker of lupus nephritis: a multicenter cohort study.

Urinary TWEAK as a biomarker of lupus nephritis: a multicenter cohort study.

http://www.wikidata.org/entity/Q37453911

about

TWEAK and the progression of renal disease: clinical translation Lupus nephritis: the evolving role of novel therapeutics A Bioinformatics Resource for TWEAK-Fn14 Signaling Pathway The pathogenesis, diagnosis and treatment of lupus nephritis.Systemic lupus erythematosus diagnostics in the 'omics' era Urinary biomarkers in lupus nephritis.TWEAK enhances E-selectin and ICAM-1 expression, and may contribute to the development of cutaneous vasculitis.OX40/OX40L in systemic lupus erythematosus: association with disease activity and lupus nephritis.Colony-stimulating factor-1: a potential biomarker for lupus nephritis.TWEAK-Fn14 as a mediator of acute kidney injury.TWEAK/Fn14 system and crescent formation in IgA nephropathy.Dialogue: A blissful future for lupus nephritis: harnessing repeat kidney biopsies to identify meaningful biomarkers of disease.Deficiency of fibroblast growth factor-inducible 14 (Fn14) preserves the filtration barrier and ameliorates lupus nephritis.Biomarkers for kidney involvement in pediatric lupus.Urinary neutrophil gelatinase-associated lipocalin is a potential biomarker for renal damage in patients with systemic lupus erythematosus.Lupus nephritis: an overview of recent findings.Urinary TWEAK level as a marker of lupus nephritis activity in 46 cases.The Pathogenesis and Therapeutic Implications of Tubulointerstitial Inflammation in Human Lupus Nephritis Inhibition of the TWEAK/Fn14 pathway attenuates renal disease in nephrotoxic serum nephritis Fn14-Fc suppresses germinal center formation and pathogenic B cells in a lupus mouse model via inhibition of the TWEAK/Fn14 Pathway.Urinary angiostatin--a novel putative marker of renal pathology chronicity in lupus nephritis.Neuropsychiatric disease in murine lupus is dependent on the TWEAK/Fn14 pathway.Plasma levels of osteopontin identify patients at risk for organ damage in systemic lupus erythematosus Tumor Necrosis Factor-Like Weak Inducer of Apoptosis Accelerates the Progression of Renal Fibrosis in Lupus Nephritis by Activating SMAD and p38 MAPK in TGF-β1 Signaling Pathway Biomarkers in systemic lupus erythematosus: challenges and prospects for the future.The role of soluble tumor necrosis factor like weak inducer of apoptosis and interleukin-17A in the etiopathogenesis of celiac disease: A cross-sectional study.Biomarkers and updates on pediatrics lupus nephritis.A discrete cluster of urinary biomarkers discriminates between active systemic lupus erythematosus patients with and without glomerulonephritis.Is TWEAK a Biomarker for Autoimmune/Chronic Inflammatory Diseases?International validation of a urinary biomarker panel for identification of active lupus nephritis in children.Expression of tumor necrosis factor-like weak inducer of apoptosis and fibroblast growth factor-inducible 14 in patients with polymyositis and dermatomyositis.Biomarkers for lupus nephritis: a critical appraisal.Treatment of proliferative lupus nephritis: a slowly changing landscape.The role of cytokines as biomarkers in systemic lupus erythematosus and lupus nephritis.Tumor necrosis factor-like weak inducer of apoptosis and its potential roles in lupus nephritis.Urine biomarkers in juvenile-onset SLE nephritis.Role of TWEAK in lupus nephritis: a bench-to-bedside review.Diagnosis and treatment of lupus nephritis flares--an update.The TWEAK-Fn14 system as a potential drug target.Promising biomarkers for systemic lupus erythematosus.

P2860

Q26996775-97710F4B-B0DF-4AB6-9F22-00B9A5FF0DE9 Q26998390-D91B7C0C-026E-497A-BE52-2939FD24FE91 Q28729829-035BFF3A-4F00-48DB-824D-4EFD17E8FD95 Q30596968-349BDC45-2EB6-47D2-A861-18D8E553D2AD Q33644106-74A0C9B1-2267-4065-A450-48A5026A7623 Q34050022-F16C7F8D-F231-4DD0-9DF2-EC061981B62F Q34607114-2B4B3F0B-9BA3-4CA1-BDE0-FE6CE7BB15F0 Q35006093-1AE006FA-E216-4A3E-A627-B7384E6D937F Q35027273-0282A6D3-7756-4AC4-B100-ED694806EB24 Q35073736-49E1B643-2FB9-4038-ABAB-7625D31DAAB1 Q35187418-9A9E0DDB-ACB6-41F1-845F-AD57F71BEEBF Q35280905-79B71FCF-2AC4-4C87-A24F-369FFF421439 Q35550587-4DD9DAB6-95E4-4FAE-A216-85C2D4E0751E Q35810911-33B3D3E6-3186-40BD-8D54-27A3473733CB Q35830106-A4B60551-68D1-4264-AB0A-07BB86927468 Q35867038-FEA7D94F-C384-421E-86B8-69FE319E28D5 Q36031863-88B12AF5-781C-493A-9019-D64F16F5F267 Q36299959-15289DEC-3355-4865-8DEA-ACDDAB196051 Q36354235-5F7DD1AA-1654-4735-9399-E64D6C5C972C Q36820363-39249188-439F-4268-9468-AE0A3471F77E Q36832462-8EFFD2FC-0D93-453A-B9A2-FBA594F91209 Q36902003-3D230024-4018-4AA9-B212-1892517570DF Q36903365-D57D88F2-1D43-42AA-B534-A0B92357D247 Q37018721-B3398CAC-A337-4C58-9E39-0077C4240AFF Q37058781-132324A5-E488-40CD-B927-85B0B192AD4D Q37077884-FB53101F-09CE-4834-8D90-88CC17256A2E Q37167062-F870F61C-F185-4CA0-8869-552317B7E815 Q37311370-81EBF439-E4BD-43A3-9C60-D2CC425345C8 Q37415529-E3ED2449-E813-4AF3-9FBA-05330760EE50 Q37547407-37A14F59-55B9-4D44-B694-E1930BCB7567 Q37690660-17C1E1A6-8ED1-4A65-991A-D8B751B59EB4 Q37736277-73DEC4DA-5E7B-4084-9544-E66040FC6DA2 Q37822658-CBA2047D-E39D-4EE0-8B8E-2C81F7B938F6 Q37849465-979F3E74-99C3-4C73-99EF-8FA2C672539F Q37980604-9F9DA24B-1C64-4D02-88F6-FD4F6E784CA1 Q38010347-EEB0808B-81AF-4D0B-9323-FE610FB9C807 Q38021183-5673E9C2-F0E4-43D6-AC9F-64460410A35D Q38059445-646D1EBA-4853-4B71-9AC1-876CF7B0C804 Q38129961-6C634C6F-D0D5-41EC-A369-681F72C69B7F Q38149960-F8F284F3-D48A-4448-8EC4-60F17FAC2AF0

P2860

Urinary TWEAK as a biomarker of lupus nephritis: a multicenter cohort study.

http://www.wikidata.org/entity/Q37453911

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 28 September 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Urinary TWEAK as a biomarker of lupus nephritis: a multicenter cohort study.

@en

Urinary TWEAK as a biomarker of lupus nephritis: a multicenter cohort study.

@nl

type

label

Urinary TWEAK as a biomarker of lupus nephritis: a multicenter cohort study.

@en

Urinary TWEAK as a biomarker of lupus nephritis: a multicenter cohort study.

@nl

prefLabel

Urinary TWEAK as a biomarker of lupus nephritis: a multicenter cohort study.

@en

Urinary TWEAK as a biomarker of lupus nephritis: a multicenter cohort study.

@nl

P1433

Q37453911-7D60ED0C-DC36-4C1E-8D5F-A560DFCE9F8B

P1476

Q37453911-3F9853F9-B093-4C69-95C4-CD58FFAA31EA

P2093

Q37453911-0B7A6154-59E6-47A0-8F55-60F3C73CCF02

Q37453911-28D9590D-1530-49B5-8FFC-C12311407A54

Q37453911-3084F6C6-24E9-4A70-98F6-B9AF506A2F81

Q37453911-337843B7-3E37-438C-A753-6DB9C299233D

Q37453911-394C42D8-A68E-44D8-8F5B-79BA658C9180

Q37453911-3F0202F3-B4B5-4552-A1CE-2A6AE5FCCFC6

Q37453911-6950627D-7572-4FD2-952E-CE2280A0036E

Q37453911-74A71FAA-BF35-43D5-B8D4-606E7E3C557E

Q37453911-7CD27FEB-065D-484E-B057-37B528558222

Q37453911-87C300D8-52D8-4135-9FCC-4F6376252F54

P2860

Q37453911-0045F65B-5977-4596-8D21-36DD4B142A7C

Q37453911-07ACB648-CA62-4C4F-82F0-470F19EAC55B

Q37453911-0B9F8B5B-BBA3-4BC4-942D-ADF10ADEB507

Q37453911-197743E1-6251-4261-97C4-1EAEEF7D6C53

Q37453911-1E581E73-91D4-4E18-AF56-800E3FBF6B88

Q37453911-252B6859-C726-4C4A-9B89-7BC5EC776FE2

Q37453911-3035B3E5-8612-43DC-9F94-F3E0FA1AD291

Q37453911-35ABE630-E71D-4493-B72C-9B953EB5285B

Q37453911-3C53ACC5-3F92-470E-B8DC-52F75BA87C55

Q37453911-3D975658-4008-4377-8B66-7C18B195A79F

P2888

Q37453911-2FCCB00E-8845-4802-B5F9-C9715E32FD6E

P304

Q37453911-88E73313-2328-4112-8771-D9FE2C9D1C78

P31

Q37453911-2076A29E-1672-4BFE-ABB7-74BE73CFC4F0

P356

Q37453911-2F7956A5-DB94-4621-8400-3450A445B317

P433

Q37453911-FD918C53-081E-4242-827D-F4529F227EA5

P478

Q37453911-A365D743-3E29-41BA-A03A-B433697596B1

P50

Q37453911-1DFE9EA3-D9F0-4FC4-8544-2EB48BCFD41F

P577

Q37453911-13E14C2A-C592-4D0F-8D4D-E900EE50C104

P5875

Q37453911-51CEADF4-F7D8-461C-9D9A-5C1D6D5E7597

P6179

Q37453911-A2795463-2E34-447A-9E1F-C71EA9CC3C6A

P698

Q37453911-3682BDE1-72AD-4ACC-B9E0-313EDD594452

P921

Q37453911-0BC9A7E3-D54E-4BB8-B496-72DAF5B25A95

Q37453911-A59FE9F4-29B4-4A57-B6C4-07D4C768AE3F

P932

Q37453911-9CC51C07-3D2E-451C-985A-5058FE4FB049

P356

P1433

Arthritis Research and Therapy

P1476

Urinary TWEAK as a biomarker of lupus nephritis: a multicenter cohort study

@en

P2093

Bernard Hojaili

http://www.w3.org/2001/XMLSchema#string

Brad H Rovin

http://www.w3.org/2001/XMLSchema#string

Chaim Putterman

http://www.w3.org/2001/XMLSchema#string

Cynthia Aranow

http://www.w3.org/2001/XMLSchema#string

Irene Blanco

http://www.w3.org/2001/XMLSchema#string

Jennifer S Michaelson

http://www.w3.org/2001/XMLSchema#string

Lihe Su

http://www.w3.org/2001/XMLSchema#string

Linda C Burkly

http://www.w3.org/2001/XMLSchema#string

Meggan Mackay

http://www.w3.org/2001/XMLSchema#string

Noa Schwartz

http://www.w3.org/2001/XMLSchema#string

P2860

Proinflammatory activity of TWEAK on human dermal fibroblasts and synoviocytes: blocking and enhancing effects of anti-TWEAK monoclonal antibodies

TWEAK induces angiogenesis and proliferation of endothelial cells

Dual role for TWEAK in angiogenic regulation

Multiple pathways of TWEAK-induced cell death

Pro-inflammatory effect of TWEAK/Fn14 interaction on human umbilical vein endothelial cells

Fibroblast growth factor-inducible 14 mediates multiple pathways of TWEAK-induced cell death

TWEAK, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosis

The 1982 revised criteria for the classification of systemic lupus erythematosus

Biomarker discovery in human SLE nephritis.

Biomarkers in systemic lupus erythematosus: II. Markers of disease activity.

P2888

P304

R143

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/AR2816

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P50

Christopher E Collins

P577

2009-09-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26852681

http://www.w3.org/2001/XMLSchema#string

P6179

1020733895

http://www.w3.org/2001/XMLSchema#string

P698

19785730

http://www.w3.org/2001/XMLSchema#string

P921

multicenter trial

P932

2787265

http://www.w3.org/2001/XMLSchema#string